TuHURA Biosciences IncNASDAQ:HURA
- LAST PRICE3.3500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.9600/ 1
- Ask / Lots3.4900/ 4
- Open / Previous Close--- / 3.3500
- Day Range---
- 52 Week Range
- Volume150
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HURA |
|---|---|---|
| 09:32 ET | 3291 | 3.46 |
| 09:44 ET | 600 | 3.3385 |
| 09:46 ET | 500 | 3.3 |
| 10:04 ET | 200 | 3.3699 |
| 10:11 ET | 100 | 3.2607 |
| 10:15 ET | 1906 | 3.16 |
| 10:18 ET | 1740 | 3.08 |
| 10:20 ET | 601 | 3.08 |
| 10:22 ET | 399 | 3.0393 |
| 10:24 ET | 773 | 3.0243 |
| 10:26 ET | 950 | 3 |
| 10:27 ET | 819 | 3 |
| 10:29 ET | 300 | 3 |
| 10:36 ET | 100 | 3.09 |
| 10:38 ET | 100 | 3.03 |
| 10:40 ET | 745 | 3.0523 |
| 10:42 ET | 400 | 3.07 |
| 10:54 ET | 133 | 3.0699 |
| 10:58 ET | 812 | 3.06 |
| 11:14 ET | 100 | 3.035 |
| 11:16 ET | 100 | 2.99 |
| 11:21 ET | 10395 | 3.11 |
| 11:23 ET | 338 | 3.14 |
| 11:25 ET | 248 | 3.14 |
| 11:30 ET | 200 | 3.13 |
| 11:32 ET | 100 | 3.225 |
| 11:43 ET | 214 | 3.2727 |
| 11:45 ET | 190 | 3.3 |
| 11:54 ET | 1240 | 3.39 |
| 11:56 ET | 100 | 3.39 |
| 12:17 ET | 100 | 3.43 |
| 12:42 ET | 400 | 3.34 |
| 12:55 ET | 100 | 3.245 |
| 12:57 ET | 100 | 3.2644 |
| 01:02 ET | 100 | 3.25 |
| 01:04 ET | 2709 | 3.295 |
| 01:06 ET | 1591 | 3.42 |
| 01:18 ET | 306 | 3.43 |
| 01:20 ET | 300 | 3.39 |
| 01:31 ET | 143 | 3.2794 |
| 01:40 ET | 124 | 3.35 |
| 01:45 ET | 200 | 3.32 |
| 01:47 ET | 200 | 3.28 |
| 02:02 ET | 324 | 3.26 |
| 02:18 ET | 100 | 3.403 |
| 02:56 ET | 100 | 3.38 |
| 03:08 ET | 300 | 3.28 |
| 03:17 ET | 200 | 3.39 |
| 03:28 ET | 1080 | 3.37 |
| 03:30 ET | 100 | 3.29 |
| 03:44 ET | 952 | 3.2701 |
| 03:46 ET | 100 | 3.36 |
| 03:53 ET | 100 | 3.36 |
| 03:55 ET | 500 | 3.331 |
| 03:57 ET | 100 | 3.36 |
| 04:00 ET | 960 | 3.35 |
Oct 23, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TuHURA Biosciences Inc | 140.8M | -0.3x | --- |
PepGen Inc | 140.8M | -1.5x | --- |
Acumen Pharmaceuticals Inc | 138.8M | -1.7x | --- |
Cytodyn Inc | 144.1M | -4.9x | --- |
Black Diamond Therapeutics Inc | 137.5M | -1.8x | --- |
Inhibikase Therapeutics Inc | 135.1M | -0.7x | --- |
Company Information
TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first line treatment for advanced Merkel cell carcinoma. In addition, the Company is leveraging its Delta receptor technology to develop novel bi-functional antibody drug conjugates (ADCs), targeting myeloid derived suppressor cells to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. Its IFx platform technology utilizes a proprietary plasmid DNA (pDNA) or messenger RNA (mRNA).
Contact Information
- Headquarters
- 10500 University Center Dr., Suite 110TAMPA, FL, United States 33612
- Phone
- 813-875-6600
- Fax
- 604-202-1384
Executives
- Chairman of the Board
- Robert Hoffman
- Chief Executive Officer, Director
- James Bianco
- Chief Financial Officer
- Daniel Dearborn
- Senior Vice President, Business Development
- John Liatos
- Chief Scientific Officer
- Dennis Yamashita
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $140.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 42.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-12.70 |
Book Value | $2.38 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
